| Previous Close | 0.0378 |
| Open | 0.0400 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0375 - 0.0420 |
| 52 Week Range | 0.0250 - 0.1998 |
| Volume | 3,116,477 |
| Avg. Volume | 573,159 |
| Market Cap | 10.487M |
| Beta (5Y Monthly) | 0.58 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1340 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Sproutly Enters into LOI with CannaHive Inc.
Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company"), has executed a Letter of Intent (the "LOI") to enter into a commercial relationship with CannaHive Inc. ("CannaHive"). The agreement will allow Sproutly to further expand its Cannabis 2.0 product offerings produced by the Company’s wholly-owned subsidiary, Toronto Herbal Remedies Inc. ("THR").
- Business Wire
Sproutly Issues Shares in Lieu of Interest
Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company") announces that the Company, pursuant to a convertible debenture indenture dated October 24, 2018 between the Company and TSX Trust Company, as trustee, which has been amended pursuant to a first supplemental indenture dated April 24, 2020, a second supplemental indenture dated July 23, 2020 and a third supplemental indenture dated September 23, 2020 (collectively, the "Indenture"), intends to settle $124,000 in accrued and unpaid interest (the "Interest") under the Indenture. In settlement of the Interest, the Company intends to issue 2,480,000 common shares in the capital of the Company (the "Settlement Shares") at a price of $0.05 per Settlement Share.
- Business Wire
Sproutly Enters Into LOI With Cannabis Manufacturer’s Guild Ltd.
Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company"), has executed a Letter of Intent (the "LOI") to enter into a commercial relationship with Cannabis Manufacturer’s Guild Ltd. ("CMG"). The agreement will allow Sproutly to expand and diversify its flower and Cannabis 2.0 product offerings utilizing brands developed by CMG and its affiliates (the "Acquired Products"), through the Company’s wholly-owned subsidiary, Toronto Herbal Remedies Inc. ("THR").
